TD Asset Management »

Eliem Therapeutics shares owned by TD Asset Management

Quarter-by-quarter ownership of Eliem Therapeutics (ELYM) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by TD Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $445k 89k 4.98

More positions owned by TD Asset Management

Microsoft Corporation (MSFT)
Apple (AAPL)
Rbc Cad (RY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Toronto Dominion Bk Ont Com New (TD)
Meta Platforms Cl A (META)
Canadian Pacific Kansas City (CP)
Amazon (AMZN)
Bank Of Montreal Cadcom (BMO)
Enbridge (ENB)
Broadcom (AVGO)
Canadian Natural Resources (CNQ)
Cibc Cad (CM)
UnitedHealth (UNH)

View all positions for TD Asset Management

Top funds holding Eliem Therapeutics

RA Capital Management
Deep Track Capital
Samsara BioCapital
Henderson Group
Boxer Capital
Affinity Asset Advisors
Driehaus Capital Management
Geode Capital Management
BlackRock
Vanguard Group
Sphera Funds Management
Ikarian Capital
TD Asset Management
Charles Schwab Investment Management
Bank of New York Mellon

View all funds holding Eliem Therapeutics